Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

On this episode of JHLT: The Podcast , the Digital Media Editors invite co-lead author Nir Uriel, MD , Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University. Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, " Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis ." The discussion explores: Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs) Why the study might show fewer SAEs than the literature historically shows How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock The ongoing and upcoming activities of CSWG For the latest studies from JHLT , visit , or, if you're an ISHLT member, access your Journal membership at . Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at for a free subscription, or

You can listen to Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days is an episode from JHLT: The Podcast by Jessica Burke.

This episode is 21:09 long.

This episode was published on Oct 15, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JHLT: The Podcast when more episodes are available from the podcast feed.